Molecular basis of agonist binding to the type A cholecystokinin receptor

Pharmacology and Toxicology

Volumn 91, Issue 6, 2002, Pages 282-285

  Miller, Laurence J ^a,b,c   Lybrand, Terry P ^a,b  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR; CARBOXYL GROUP; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; G PROTEIN COUPLED RECEPTOR; RHODOPSIN; TYROSINE SULFATE;

AGONIST; CONFERENCE PAPER; MOLECULAR INTERACTION; MOLECULAR MODEL; MUTAGENESIS; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RATS; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036968574     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910603.x     Document Type: Conference Paper

References (25)

1. Aquino, C. J., D. R. Armour, J. M. Berman, L. S. Birkemo, R. A. E. Carr, D. K. Croom, M. Dezube, R. W. Dougherty, Jr., G. N. Ervin, M. K. Grizzle, J. E. Head, G. C. Hirst, M. K. James, M. F. Johnson, L. J. Miller, K. L. Queen, T. J. Rimele, D. N. Smith & E. E. Sugg: Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity 1. Optimization of the agonist "Trigger". J. Med. Chem. 1996, 39, 562-569.
2. Charpentier, B., D. Pelaprat, C. Durieux, A. Dor, M. Reibaud, J. C. Blanchard & B. P. Roques: Cyclic cholecystokinin analogues with high selectivity for central receptors. Proc. Natl. Acad. Sci. USA 1988, 85, 1968-1972.
3. Cheng, Z. J. & L. J. Miller: Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. 2001, 276, 48040-28047.
4. Darrow, J. W., E. M. Hadac, L. J. Miller & E. E. Sugg: Structurally similar small molecule photoaffinity CCK-A agonists and antagonists as novel tools for directly probing 7TM receptor-ligand interactions. Bioorg. Med. Chem. Lett. 1998, 8, 3127-3132.
5. Ding, X. Q., V. Dolu, E. M. Hadac, E. L. Holicky, D. I. Pinon, T. P. Lybrand & L. J. Miller: Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe. J. Biol. Chem. 2001, 276, 4236-4244.
6. Ding, X. Q., D. I. Pinon, K. E. Furse, T. P. Lybrand & L. J. Miller: Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor. Mol. Pharmacol. 2002, 61, 1041-1052.
7. Galardy, R. E., L. C. Craig, J. D. Jamieson & M. P. Printz: Photoaffinity labeling of peptide hormone binding sites. J. Biol. Chem. 1974, 249, 3510-3518.
8. Gigoux, V., C. Escrieut, J. A. Fehrentz, S. Poirot, B. Maigret, L. Moroder, D. Gully, J. Martinez, N. Vaysse & D. Fourmy: Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J. Biol. Chem. 1999, 274, 20457-20464.
9. Go, W. Y., E. L. Holicky, E. M. Hadac, R. V. Rao & L. J. Miller: Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking. Amer. J. Physiol. 1998, 275, G56-G62.
10. 1 receptor for interactions with SR 146131, SR 27897 and CCK-8S. Eur. J. Pharmacol. 2000, 389, 115-124.
11. Hadac, E. M., Z. S. Ji, D. I. Pinon, R. M. Henne, T. P. Lybrand & L. J. Miller: A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: Dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely. J. Med. Chem. 1999, 42, 2105-2111.
12. Hadac, E. M., D. I. Pinon, Z. Ji, E. L. Holicky, R. Henne, T. Lybrand & L. J. Miller: Direct identification of a second distinct site of contact between cholecystokinin and its receptor. J. Biol. Chem. 1998, 273, 12988-12993.
13. Hruby, V. J., S. A. Fang, R. Knapp, W. Kazmierski, G. K. Lui & H. I. Yamamura: Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors. Int. J. Pept. Protein Res. 1990, 35, 566-573.
14. Ji, Z. S., E. M. Hadac, R. M. Henne, S. A. Patel, T. P. Lybrand & L. J. Miller: Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. J. Biol. Chem. 1997, 272, 24393-24401.
15. Kennedy, K., V. Gigoux, C. Escrieut, J. Martinez, L. Moroder, D. Frehel, D. Gully, N. Vayse & D. Fourmy: Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J. Biol. Chem. 1997, 272, 2920-2926.
16. Klueppelberg, U. G., S. P. Powers & L. J. Miller: The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of cross-linkable and photolabile probes. Receptor 1990, 1, 1-11.
17. Loomis, R. E., P. C. Lee & C. C. Tseng: Conformational analysis of the cholecystokinin C-terminal octapeptide: a nuclear magnetic resonance and computer- simulation approach. Biochim. Biophys. Acta 1987, 911, 168-179.
18. Moroder, L., A. D'Ursi, D. Picone, P. Amodeo & P. A. Temussi: Solution conformation of CCK9, a cholecystokinin analog. Biochem. Biophys. Res. Commun. 1993, 190, 741-746.
19. Ondetti, M. A., B. Rubin, S. L. Engel, J. Pluscec & J. T. Sheehan: Cholecystokinin-pancreozymin. Recent developments. Amer. J. Dig. Dis. 1970, 15, 149-156.
20. Palczewski, K., T. Kumasaka, T. Hori, C. A. Behnke, H. Motoshima, B. A. Fox, I. Le. Trong, D. C. Teller, T. Okada, R. E. Stenkamp, M. Yamamoto & M. Miyano: Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
21. Pearson, R. K. & L. J. Miller: Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor. J. Biol. Chem. 1987, 262, 869-876.
22. Silvente-Poirot, S., C. Escrieut & S. A. Wank: Role of the extracellular domains of the cholecystokinin receptor in agonist binding. Mol. Pharmacol. 1998, 54, 364-371.
23. Strader, C. D., T. Gaffney, E. E. Sugg, M. R. Candelore, R. Keys, A. A. Patchett & R. A. F. Dixon: Allele-specific activation of genetically engineered receptors. J. Biol. Chem. 1991, 266, 5-8.
24. Wank, S. A., R. Harkins, R. T. Jensen, H. Shapira, A. De Weerth & T. Slattery: Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 3125-3129.
25. Zaluski, M. C. Fournie, J. Belleney, B. Lux, C. Durieux, D. Gerard, G. Gacel, B. Maigret & B. P. Roques: Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations. Biochemistry 1986, 25, 3778-3787.